Veeva Systems Inc.

VEEV Healthcare Health Information Services

Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.

310.30 2.73 −0.87%
Market cap
$50.7B
P/E
50.0×
Fwd P/E
26.9×
Dividend yield
—
F-score
7/9
Altman Z
13.57
Beneish M
−2.63
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jan '26 Jan '25 Jan '24 Jan '23 Jan '22 Jan '21 Jan '20 Jan '19 Jan '18 Jan '17
Revenue
3,195.31 2,746.62 2,363.67 2,155.06 1,850.78 1,465.07 1,104.08 862.21 690.56 550.54
Revenue Growth
16.34% 16.20% 9.68% 16.44% 26.33% 32.70% 28.05% 24.86% 25.43% 34.53%
Cost of Revenue
782.02 699.64 677.29 609.41 503.68 408.93 303.37 245.28 211.42 173.68
Gross Profit
2,413.29 2,046.98 1,686.38 1,545.66 1,347.10 1,056.14 800.71 616.93 479.14 376.86
R&D Expenses
767.39 693.08 629.03 520.28 382.04 294.22 209.90 158.78 132.02 96.74
SG&A Expenses
729.54 662.47 628.02 566.29 459.57 384.13 304.60 235.28 189.19 159.43
Operating Income
916.37 691.43 429.33 459.09 505.50 377.79 286.22 222.87 157.93 120.69
Non-operating Income/Expense
278.14 227.95 158.69 50.01 6.82 16.20 27.48 15.78 7.84 1.67
EBT
1,194.51 919.38 588.02 509.10 512.31 393.99 313.70 238.64 165.77 122.36
Income Tax Provision
285.60 205.24 62.32 21.39 84.92 14.00 12.58 8.81 14.59 44.78
Income after Tax
908.91 714.14 525.71 487.71 427.39 380.00 301.12 229.83 151.18 77.57
Dividends (Preferred)
— — — — — — — — — 0.00
Net Income Common
908.91 714.14 525.71 487.71 427.39 380.00 301.12 229.83 151.18 77.57
EPS (Basic)
5.55 4.41 3.27 3.14 2.79 2.52 2.03 1.59 1.01 0.51
EPS (Diluted)
5.44 4.32 3.22 3.00 2.63 2.36 1.90 1.47 0.92 0.47
Shares (Basic, Weighted)
163.67 161.88 160.53 155.39 153.25 150.67 147.80 144.24 140.31 135.70
Shares (Diluted, Weighted)
167.00 165.23 163.49 162.44 162.28 160.73 158.30 156.12 153.68 147.58
Gross Margin
75.53% 74.53% 71.35% 71.72% 72.79% 72.09% 72.52% 71.55% 69.38% 68.45%
EBIT Margin
28.68% 25.17% 18.16% 21.30% 27.31% 25.79% 25.92% 25.85% 22.87% 21.92%
EBT margin
37.38% 33.47% 24.88% 23.62% 27.68% 26.89% 28.41% 27.68% 24.01% 22.22%
Net Profit Margin
28.44% 26.00% 22.24% 22.63% 23.09% 25.94% 27.27% 26.66% 21.89% 14.09%
Free Cash Flow Margin
43.38% 38.94% 37.45% 35.59% 40.54% 37.03% 39.22% 34.91% 32.16% 24.79%
EBITDA
961.07 721.90 453.62 506.68 565.26 431.06 323.33 252.88 190.24 150.55
EBIT
916.37 691.43 429.33 459.09 505.50 377.79 286.22 222.87 157.93 120.69
Income from Continuous Operations
908.91 714.14 525.71 487.71 427.39 380.00 301.12 229.83 151.18 77.57
Consolidated Net Income/Loss
908.91 714.14 525.71 487.71 427.39 380.00 301.12 229.83 151.18 77.57
EPS (Basic, from Continuous Ops)
5.55 4.41 3.27 3.14 2.79 2.52 2.04 1.59 1.08 0.57
EPS (Basic, Consolidated)
5.55 4.41 3.27 3.14 2.79 2.52 2.04 1.59 1.08 0.57
EPS (Diluted, from Cont. Ops)
5.44 4.32 3.22 3.00 2.63 2.36 1.90 1.47 0.98 0.53
Shares (Diluted, Average)
167.00 165.23 163.49 162.44 162.28 160.73 158.30 156.12 153.68 147.58
EPS (Diluted, Consolidated)
5.44 4.32 3.22 3.00 2.63 2.36 1.90 1.47 0.98 0.53
EBITDA Margin
30.08% 26.28% 19.19% 23.51% 30.54% 29.42% 29.28% 29.33% 27.55% 27.35%
Operating Cash Flow Margin
44.29% 39.69% 38.56% 36.22% 41.30% 37.63% 39.61% 36.05% 33.80% 26.16%

Fold the line items

In millions of $ except per-share values · columns are period end dates